PMDA drug package insert
フィブリノゲンHT静注用1g「JB」
PMDA Prescription drug · 一般社団法人日本血液製剤機構 · package insert Mar 23, 2026
Key facts
| Brand names | フィブリノゲンHT静注用1g「JB」 |
|---|---|
| Nonproprietary names | 乾燥人フィブリノゲン |
| Companies | 製造販売元／一般社団法人日本血液製剤機構 |
| Product type | Prescription drug |
| Therapeutic category | 血漿分画製剤（血液凝固剤） |
| Therapeutic category codes | 876343 |
| YJ codes | 6343411X1058 |
| Approval numbers | 22700AMX00621 |
| Package insert edition | 第2版 |
| Package insert date | Mar 23, 2026 |
| PMDA document key | 580842_6343411X1058_1 |
| PMDA company code | 580842 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: